4//SEC Filing
Topper David Joseph 4
Accession 0001787306-25-000053
CIK 0001787306other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:21 PM ET
Size
5.5 KB
Accession
0001787306-25-000053
Insider Transaction Report
Form 4
Topper David Joseph
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-02$15.80/sh−9,600$151,698→ 182,774 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"), granted on April 10, 2024.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $14.61 to $17.26, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001740378
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:21 PM ET
- Size
- 5.5 KB